Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.

Banegas MP, Emerson MA, Adams AS, Achacoso NS, Chawla N, Alexeeff S, Habel LA.

J Cancer Surviv. 2018 Dec;12(6):794-802. doi: 10.1007/s11764-018-0716-6. Epub 2018 Oct 18.

PMID:
30338462
2.

Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma.

Su KA, Habel LA, Achacoso NS, Friedman GD, Asgari MM.

Br J Dermatol. 2018 Nov;179(5):1088-1094. doi: 10.1111/bjd.16713. Epub 2018 Aug 14.

3.

Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

Krieger N, Nabavi S, Waterman PD, Achacoso NS, Acton L, Schnitt SJ, Habel LA.

Cancer Causes Control. 2018 Mar;29(3):305-314. doi: 10.1007/s10552-018-1006-3. Epub 2018 Feb 9.

4.

Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009).

Krieger N, Habel LA, Waterman PD, Shabani M, Ellison-Loschmann L, Achacoso NS, Acton L, Schnitt SJ.

NPJ Breast Cancer. 2015;1. pii: 15016. Epub 2015 Oct 7.

5.

Metformin use and lung cancer risk in patients with diabetes.

Sakoda LC, Ferrara A, Achacoso NS, Peng T, Ehrlich SF, Quesenberry CP Jr, Habel LA.

Cancer Prev Res (Phila). 2015 Feb;8(2):174-9. doi: 10.1158/1940-6207.CAPR-14-0291.

6.

Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus.

Yang YX, Habel LA, Capra AM, Achacoso NS, Quesenberry CP Jr, Ferrara A, Levin TR, Lewis JD.

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3027-36. doi: 10.1158/1055-9965.EPI-10-0486. Epub 2010 Oct 11.

7.

Mammographic density and risk of second breast cancer after ductal carcinoma in situ.

Habel LA, Capra AM, Achacoso NS, Janga A, Acton L, Puligandla B, Quesenberry CP Jr.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2488-95. doi: 10.1158/1055-9965.EPI-10-0769.

8.

Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans.

Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP Jr, Habel LA.

Am J Manag Care. 2010 May;16(5):351-60.

9.

Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.

Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP Jr.

Breast Cancer Res. 2009;11(6):R85. doi: 10.1186/bcr2453. Epub 2009 Nov 18.

10.

Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery.

Nekhlyudov L, Habel LA, Achacoso NS, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP Jr, Fletcher SW.

J Clin Oncol. 2009 Jul 1;27(19):3211-6. doi: 10.1200/JCO.2008.18.5876. Epub 2009 May 11.

11.

Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus.

Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP Jr, Habel LA.

Gastroenterology. 2008 Dec;135(6):1914-23, 1923.e1. doi: 10.1053/j.gastro.2008.09.004. Epub 2008 Sep 13.

12.

Medical therapy for diabetes is associated with increased use of lower endoscopy.

Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP Jr, Habel LA.

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1195-202.

PMID:
17603822

Supplemental Content

Loading ...
Support Center